LENZ Therapeutics is progressing rapidly with its LNZ100 for presbyopia, aiming for a 2025 U.S. launch in a market valued at ...

On Thursday morning, members of East Spencer’s Board of Aldermen, mayor, a resident and a member of Centralina Council of ...

Fibrobiologics' cell therapy CYMS101 significantly increased myelin production and promoted myelin repair in a mouse model of ...

Arvinas' ARV-102 reduced LRRK2 protein in a Phase 1 trial, showing promising safety and pharmacodynamic outcomes for ...

The Hailey City Council on Monday approved a revised preliminary plat application from local developer Marathon Partners for ...

The $1 million donation has pushed Kids Inc. within striking distance of its $30 million Phase One goal, with construction ...

The Oak Bend subdivision will include a total of 110 lots upon completion of both phases. The final plat for the first phase, ...

Research reveals how specific sleep stages protect brain vulnerable to Alzheimer's, offering hope through simple lifestyle ...

Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for ...

Snap began testing Sponsored Snaps, which allow brands to deliver a vertical video directly to users’ inboxes, last October.

On display at bauma 2025 will be two new electric excavator prototypes, the TB10e and TB35e, along with the TB20e electric ...

Roche's MUSETTE trial found no additional benefit of high-dose Ocrevus over the 600 mg IV dose, reaffirming its efficacy and safety for relapsing multiple sclerosis.